Project Grant 2111981
Award Date 6/1/21
Completion Date 11/30/22
Dollars Obligated $256K
Federal Agency
Awardee
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21202, USA
Similar Awards
- This $500,000 Project Grant from the National Science Foundation's Technology, Innovation, and Partnerships program aims to develop a novel human stem cell-based microfluidic developmental toxicology platform. The University of Michigan will receive funding from September 2022 to August 2024 to conduct technological development of a repeatable, controllable, high-throughput microfluidic system for generating three-dimensional multicellular organoid models for toxicity testing. The platform seeks...
- This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Om Therapeutics Inc. will support the development of a system to enable the rapid, scalable, and cost-effective discovery of new medicines using machine learning. The project aims to encapsulate proteins and small molecules in millions of miniaturized compartments to screen for interactions that could identify novel drug candidates. The key innovations include...
- Infusense Corporation was awarded a $253,590 Project Grant from the National Science Foundation on August 15, 2021 to develop a point-of-care electrochemical platform for the rapid detection of drug toxicity. The project is being conducted under the NSF's Engineering program (CFDA 47.041), which aims to improve quality of life and economic strength through engineering research and innovation. Specifically, Infusense will leverage the one-year funding period ending July 31, 2022 to create a...
- The National Science Foundation awarded a $275,000 Project Grant to Oraliva, Inc. under the Technology, Innovation, and Partnerships program to develop a portable, programmable single cell cytology platform for the early detection of epithelial cancers. The platform will combine microfluidics and artificial intelligence to classify potentially cancerous tissue in near real-time through multiparameter single-cell analysis and automated evaluation. The objectives are to link different clinical...
- Federal Grant Award Summary Nanoplasmonics LLC received a $304,780 Phase I Small Business Innovation Research (SBIR) award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) on June 1, 2025, to develop breakthrough sensor technology for mycotoxin detection in the food supply chain. The project, based in Colorado Springs, Colorado, will be completed by May 31, 2026. The primary deliverable is an innovative detection system that...
- The National Science Foundation awarded American Nanotechnologies Inc. a $256,000 Small Business Innovation Research Phase I Project Grant under the Engineering program (CFDA 47.041) to develop a platform for printable chemical sensors. The one-year project ending November 30th, 2022 will support the creation of technology enabling the printing of chemical sensors for applications such as environmental monitoring and medical diagnostics. The NSF Engineering program aims to strengthen engineering...
- The National Science Foundation (NSF) awarded a $331,189 Project Grant under its Technology, Innovation, and Partnerships (CFDA 47.084) program to the University of Central Florida Board of Trustees. The 4-year grant, effective April 1, 2025, is focused on developing an affordable, portable platform for rapid virus detection. The innovation combines protein engineering to create stable enzymes for isothermal virus amplification, with electrochemical biosensors and microfluidics, enabling virus...
- Federal Project Grant Award Summary Virginia Tech has received a $425,118 Project Grant from the National Science Foundation (NSF) Technology, Innovation, and Partnerships program (CFDA 47.084) for the period June 1, 2025 through May 31, 2028. The award supports the development of a high-throughput portable biosensor capable of detecting known and emerging environmental toxins and health threats, including biowarfare agents, nanotechnology pollutants, fungal toxins, and chemical poisons. The...
- This $228,697 National Science Foundation award under the Engineering program (CFDA 47.041) will support the development of an optical biosensor technology to facilitate drug screening and validation efforts. Auctus Biologics, Inc. will utilize a proprietary temperature, pH, and chemically stable protein composed of two fragments that bind with antibody-like affinity and specificity. Over the one-year period ending January 2023, the company will establish the technology's suitability for...
- The National Science Foundation awarded Cytorecovery Inc. a $255,986 Small Business Technology Transfer Phase I Project Grant under the Engineering program (CFDA 47.041) on March 15, 2021. The grant funded the development of on-chip integration of sample preparation and monitoring capabilities with dielectrophoretic cell isolation techniques. The Engineering program seeks to improve quality of life and economic strength by fostering innovation and excellence in engineering research. This award...